Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Shareholders Tender 92 Percent of Shares to Hologic

NEW YORK (GenomeWeb News) – Hologic said today that Third Wave Technologies' shareholders have tendered approximately 45,225,950 shares, or around 92.1 percent of the company’s outstanding stock, as of the close of its initial offering period to acquire Third Wave, which expired last night.
Hologic said that it has begun a subsequent offering period for all remaining shares of Third Wave common stock in order to allow stockholders who have not yet tendered their shares to do so. This subsequent offering period will expire at midnight, EDT, on July 23.
Hologic said that it will pay shareholders the same $11.25 per share price that it offered in the initial offering period.
The company announced its plans to acquire Third Wave for $11.25 per share, or approximately $580 million, in early June.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.